22 March 2022
Panthera wins contract to recruit patients for Roche breast cancer study
Panthera Biopartners continues to grow its pipeline of oncology studies. The latest study now underway is a Roche phase III double-blind placebo-controlled study for advanced or metastatic breast cancer patients. Panthera will be recruiting from three sites in the UK in...
21 March 2022
Trio Healthcare liberates patients with new breathable silicone bag
A new super comfortable and secure bag developed by UK manufacturer Trio Healthcare is set to liberate the many thousands who struggle daily with the consequences of digestive or urinary surgery. Trio’s Genii for ostomates - those who have an opening (or stoma) for the...
16 March 2022
Stratified medicine company Monument Therapeutics announces two new developments
Manchester, UK, March 14, 2022: Monument Therapeutics, a stratified medicine company, today announced it will be presenting their positive preclinical results for MT1980, a lipid-based reformulation of an on-market anti-inflammatory compound, at the AD/PD conference, 15-20th...
15 March 2022
NICE releases Medtech Innovation Briefing for YOURmeds smart medication management system
HAVANT MARCH. 15, 2022 – YOURmeds Limited announced today that the National Institute for Health and Care Excellence (NICE), a public body of the Department of Health in England providing evidence-based technology recommendations by independent committees, released their...
9 March 2022
Proveca announces new partnership with ExCEEd Orphan
Proveca has announced its new partnership with ExCEEd Orphan to commercialise and distribute Sialanar® exclusively in Central and Eastern Europe (CEE). Under the terms of the agreement, ExCEEd Orphan will have exclusive rights to seek reimbursement, distribute and market...
28 February 2022
Gendius initiates GP data study to develop enhanced risk prediction tools for diabetes
UK medtech start-up Gendius has partnered with over 60 primary care practices on a data extraction study to develop enhanced risk prediction tools for people with diabetes. The study will analyse real-world data from thousands of people with diabetes in order to validate and...
7 February 2022
QV Bioelectronics Awarded £630,000 Under Innovate UK Biomedical Catalyst Award
• Funding will accelerate development of the GRACE implant to treat brain tumour patients with electric field therapy. • The project will accelerate the collection of preclinical safety and efficacy data, providing preclinical proof of concept whilst forming part of regulatory...
21 January 2022
Two new senior appointments at Manchester Imaging
Drs Ben Atkins and Jana Denzel join AI provider Manchester Imaging … Manchester Imaging Limited (MIL) the company behind AssistDent®, has announced two new appointments to its team of dental technology specialists, Drs Ben Atkins and Jana Denzel. A spokesperson explained:
7 January 2022
Alder Hey children’s hospital and Proveca announce collaboration
Alder Hey children’s hospital and Proveca Ltd are joining forces with the aim of improving medicines for children and young people. The new collaborative partnership plans to provide the best pharmaceutical treatments for children by identifying existing gaps and...
15 December 2021
Monument Therapeutics raises additional £0.5 million to take anti-neuroinflammation candidate MT1980 into clinic
Lipid reformulation of anti-inflammatory compound MT1980 for POCD accelerating into clinic in 2022 … Manchester, UK, Dec 14, 2021: Monument Therapeutics, a stratified medicine company, today announced it has raised an additional £0.5 million to accelerate the development...